Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH:ubiquinone oxidoreductase subunit B4 pseudogene 3 (NDUFB4P3) is a human pseudogene, meaning it is a genomic DNA sequence similar to a functional gene but generally non-functional due to mutations or deletions that prevent the production of a functional protein. NDUFB4P3 is related in sequence to the functional NDUFB4 gene, which encodes a non-catalytic accessory subunit of mitochondrial NADH:ubiquinone oxidoreductase (Complex I) in the electron transport chain, but NDUFB4P3 itself does not produce an active protein and is not involved in any known biological pathways, disease roles, or therapeutic targeting. The related functional gene, NDUFB4, is part of mitochondrial complex I, critical for electron transport and cellular respiration, but NDUFB4P3 does not encode this or any protein product. Being a pseudogene, NDUFB4P3 is generally not considered for therapeutic targeting and does not interact with drugs or function as a biomarker. There are no molecular functions, disease associations, or safety concerns specific to NDUFB4P3 described in the literature or major databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B4 pseudogene 3 (NDUFB4P3).